We have developedand characterized a novel IAP recruiting class of HDAC1–3 PROTACsand performed a comprehensive parallel transcriptomic analysis ofPROTACs, providing a high-powered glimpse of the transcriptional eventsthat occur upon HDAC inhibition in cancer cells. Here, HDAC9 is linked to cancer.